Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease
| Autor: | Elizabeth H. Calloway, Mitchell L. Drumm, Margaret W. Leigh, Michael R. Knowles, Michael S. Schechter, John Yeatts, Jessica E. Pittman, Mary J. Emond, Annelies Van Rie, Stephanie D. Davis, Michelle Kiser |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Pediatrics Lung business.industry Pseudomonas aeruginosa macromolecular substances Odds ratio respiratory system Lung injury Logistic regression medicine.disease medicine.disease_cause Gastroenterology Cystic fibrosis respiratory tract diseases medicine.anatomical_structure Internal medicine Pediatrics Perinatology and Child Health Epidemiology Medicine business ΔF508 |
| Zdroj: | Pediatric Pulmonology. 46:497-504 |
| ISSN: | 8755-6863 |
| DOI: | 10.1002/ppul.21397 |
| Popis: | Rationale Pseudomonas aeruginosa (Pa) is associated with poor pulmonary outcomes in cystic fibrosis (CF), but the association between age of Pa infection and severity of subsequent lung disease has not been thoroughly investigated. Objective Our goal was to determine the association between age of Pa acquisition and subsequent severity of CF lung disease. Methods Case-control study using CF Foundation Registry data of 629 ΔF508 homozygotes with severe and mild lung disease (FEV1 in the lowest and highest quartile of birth cohort, respectively). Multivariate logistic regression was performed to determine the association between age of Pa acquisition and lung disease severity. Results Earlier age of Pa infection was strongly associated with increased odds of severe lung disease. For first and persistent Pa, adjusted odds ratios for severe lung disease were 6.5 (95% CI 3.1, 13.7; P Conclusions Earlier Pa infection, particularly before 5 years of age, is strongly associated with severe CF lung disease later in life. This study is not designed to determine causality; Pa infection may be causing lung injury, or may be a marker of ongoing inflammation and lung damage in young children with CF. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text